ForteBank Joint Stock Company (KASE:ASBN)

Kazakhstan flag Kazakhstan · Delayed Price · Currency is KZT
20.50
-0.10 (-0.49%)
At close: Aug 4, 2025
-0.49%
Market Cap1.85T
Revenue (ttm)285.37B
Net Income (ttm)171.66B
Shares Out90.45B
EPS (ttm)1.90
PE Ratio10.75
Forward PEn/a
Dividend1.10 (5.41%)
Ex-Dividend Daten/a
Volume2,601,840
Average Volume8,391,229
Open20.60
Previous Close20.60
Day's Range20.03 - 22.60
52-Week Range3.03 - 45.00
Beta0.85
RSI50.27
Earnings DateAug 21, 2025

About Revance Therapeutics

ForteBank Joint Stock Company, together with its subsidiaries, provides commercial banking products and services in the Republic of Kazakhstan. The company operates through Corporate Business, Small and Medium Businesses, Retail Banking, and Investing Activities segments. The company offers loans, such as cash, collateralized, and car and preferential car loans; mortgage with collateral; refinancing services; installation payment; money transfer; forex; and debit and credit cards, as well as accepts cash and saving deposits. It also provides br... [Read more]

Industry Commercial Banks
Founded 1999
Employees 3,650
Stock Exchange Kazakhstan Stock Exchange
Ticker Symbol ASBN
Full Company Profile

Financial Performance

In 2024, KASE:ASBN's revenue was 276.15 billion, an increase of 33.75% compared to the previous year's 206.46 billion. Earnings were 160.35 billion, an increase of 37.71%.

Financial Statements

News

There is no news available yet.